What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?

被引：0
|
作者：
Beryl Otieno
Chukwuka Ibecheozor
Marlene S. Williams
机构：
[1] Greater Baltimore Medical Center,Division of Cardiology
[2] The Johns Hopkins University School of Medicine,undefined
[3] The Johns Hopkins University School of Medicine,undefined
来源：
Current Atherosclerosis Reports | 2023年 / 25卷
关键词：
Antiplatelet therapy; Ischemia; Dual antiplatelet therapy; Bleeding; Coronary heart disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：343 / 350
页数：7
相关论文
共 50 条
  • [31] Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease A Subanalysis of the Dual Antiplatelet Therapy Study
    Secemsky, Eric A.
    Yeh, Robert W.
    Kereiakes, Dean J.
    Cutlip, Donald E.
    Steg, P. Gabriel
    Massaro, Joseph M.
    Apruzzese, Patricia K.
    Mauri, Laura
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (09) : 942 - 954
  • [32] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, O.
    Perez, X.
    Pierre-Louis, B.
    Kurian, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 512 - 512
  • [33] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, Olusegun
    Perez, Xavier
    Bredy-Pierre-Louis
    Kurian, Damian
    CARDIOLOGY JOURNAL, 2016, 23 (03) : 307 - 316
  • [34] What is the appropriate duration of dual antiplatelet therapy?
    Mospan, Cortney M.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (02): : 16 - 19
  • [35] Optimal Duration for Dual Antiplatelet Therapy After Left Main Coronary Artery Stenting
    Choi, Jungho
    Kim, In-Soo
    Cho, Sungsoo
    Kim, Jung-Sun
    Hong, Sung-Jin
    Shin, Dong-Ho
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    CIRCULATION JOURNAL, 2021, 85 (01) : 59 - +
  • [36] Dual antiplatelet therapy duration: what are the drivers?
    Musumeci, Giuseppe
    Di Lorenzo, Emilio
    Valgimigli, Marco
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 : S4 - S14
  • [37] Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients
    Pierre Sabouret
    Michael P. Savage
    David Fischman
    Francesco Costa
    American Journal of Cardiovascular Drugs, 2021, 21 : 21 - 34
  • [38] Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients
    Sabouret, Pierre
    Savage, Michael P.
    Fischman, David
    Costa, Francesco
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (01) : 21 - 34
  • [39] Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review
    Elliott, Jesse
    Kelly, Shannon E.
    Bai, Zemin
    Liu, Wenfei
    Skidmore, Becky
    Boucher, Michel
    So, Derek Y. F.
    Wells, George A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (08) : 1039 - 1046
  • [40] Duration of Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease The Key Might Be in the Type of Drug
    Lozano, Inigo
    Rondan, Juan
    Vegas, Jose M.
    Segovia, Eduardo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (14) : 1467 - 1468
12345